Related Articles
Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age
BRAFV600E mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: Different histological subtypes and preoperative lymph node status should be taken into account
Cellular apoptosis susceptibility (CAS) is overexpressed in thyroid carcinoma and maintains tumor cell growth: A potential link to the BRAFV600E mutation
Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification